Profile data is unavailable for this security.
About the company
ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.
- Revenue in USD (TTM)28.07m
- Net income in USD-17.98m
- Incorporated1998
- Employees107.00
- LocationClearpoint Neuro Inc120 S. SIERRA AVENUE, SUITE 100SOLANA BEACH 92075United StatesUSA
- Phone+1 (949) 900-6833
- Fax+1 (949) 900-6834
- Websitehttps://www.clearpointneuro.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delcath Systems Inc | 11.88m | -56.33m | 252.00m | 76.00 | -- | 59.97 | -- | 21.22 | -2.55 | -2.55 | 0.505 | 0.1501 | 0.4322 | 0.6198 | 6.17 | 156,289.50 | -204.97 | -116.57 | -356.98 | -243.21 | 77.05 | 71.02 | -474.22 | -1,235.37 | 2.04 | -54.37 | 0.5172 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
| Zynex Inc | 193.61m | 6.04m | 257.75m | 1.10k | 46.83 | 7.99 | 24.36 | 1.33 | 0.1734 | 0.1734 | 5.73 | 1.02 | 1.41 | 2.56 | 6.85 | 176,012.70 | 4.40 | 14.58 | 4.99 | 17.52 | 80.36 | 79.62 | 3.12 | 10.44 | 3.22 | 5.74 | 0.642 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Alpha Teknova Inc | 34.94m | -34.27m | 271.85m | 210.00 | -- | 2.64 | -- | 7.78 | -0.9295 | -0.9295 | 0.9167 | 1.93 | 0.2819 | 2.36 | 6.84 | 166,381.00 | -27.65 | -- | -32.36 | -- | 22.38 | -- | -98.08 | -- | 3.28 | -29.50 | 0.144 | -- | -11.43 | -- | 22.52 | -- | -- | -- |
| Atlantic International Corp | 205.26m | -62.29m | 297.25m | 7.00 | -- | 11.68 | -- | 1.45 | -8.72 | -8.72 | 14.59 | 0.5222 | 2.91 | -- | 7.03 | 29,322,780.00 | -88.44 | -71.97 | -174.30 | -106.09 | 10.70 | 61.01 | -30.35 | -1,471.82 | -- | -1.33 | 0.7735 | -- | -100.00 | -- | -37.43 | -- | -- | -- |
| AngioDynamics, Inc. | 303.91m | -184.35m | 303.69m | 748.00 | -- | 1.48 | -- | 0.9993 | -4.57 | -4.57 | 7.56 | 5.08 | 0.7148 | 2.57 | 6.30 | 406,302.10 | -43.36 | -16.38 | -54.60 | -18.70 | 50.90 | 52.95 | -60.66 | -30.49 | 1.46 | -- | 0.00 | -- | -10.28 | 2.35 | -251.53 | -- | 13.09 | -- |
| OraSure Technologies, Inc. | 273.54m | 27.03m | 322.88m | 638.00 | 11.99 | 0.7582 | 8.10 | 1.18 | 0.3611 | 0.3611 | 3.68 | 5.71 | 0.5947 | 2.72 | 6.02 | 428,738.30 | 6.00 | 0.7238 | 6.53 | 0.8212 | 44.62 | 46.94 | 10.09 | 1.13 | 10.84 | -- | 0.0018 | 0.00 | 4.64 | 17.41 | 413.17 | 82.20 | 10.18 | -- |
| Cerus Corp | 194.51m | -24.06m | 333.54m | 288.00 | -- | 6.73 | -- | 1.71 | -0.1319 | -0.1319 | 1.07 | 0.2673 | 1.01 | 1.98 | 8.40 | 675,371.50 | -12.56 | -25.99 | -19.03 | -40.62 | 60.79 | 61.90 | -12.41 | -35.81 | 1.83 | -1.51 | 0.6244 | -- | -0.8061 | 19.69 | 12.37 | -- | 32.07 | -- |
| Pulmonx Corp | 76.58m | -57.86m | 335.93m | 279.00 | -- | 3.32 | -- | 4.39 | -1.50 | -1.50 | 1.99 | 2.58 | 0.4188 | 1.21 | 7.65 | 274,491.00 | -31.64 | -26.27 | -35.08 | -28.97 | 74.19 | 71.95 | -75.56 | -93.76 | 7.92 | -- | 0.2688 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Sight Sciences Inc | 79.40m | -52.32m | 337.06m | 214.00 | -- | 3.30 | -- | 4.25 | -1.06 | -1.06 | 1.61 | 2.03 | 0.474 | 1.53 | 4.18 | 371,004.70 | -31.24 | -38.78 | -34.01 | -42.20 | 85.80 | 80.74 | -65.90 | -105.14 | 10.50 | -26.50 | 0.2494 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Treace Medical Concepts Inc | 198.53m | -63.68m | 338.32m | 516.00 | -- | 3.02 | -- | 1.70 | -1.03 | -1.03 | 3.21 | 1.80 | 0.8347 | 1.14 | 7.52 | 384,753.90 | -26.77 | -- | -31.74 | -- | 80.67 | -- | -32.08 | -- | 2.93 | -- | 0.3216 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Tactile Systems Technology Inc | 281.54m | 32.59m | 339.61m | 992.00 | 10.38 | 1.69 | 8.66 | 1.21 | 1.37 | 1.37 | 11.81 | 8.37 | 1.02 | 7.10 | 6.36 | 283,814.50 | 11.80 | 0.9015 | 13.87 | 1.09 | 50.63 | 49.10 | 11.58 | 0.8309 | 3.89 | -- | 0.1211 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Clearpoint Neuro Inc | 28.07m | -17.98m | 342.19m | 107.00 | -- | 10.65 | -- | 12.19 | -0.7062 | -0.7062 | 1.10 | 1.16 | 0.5602 | 1.31 | 8.95 | 262,327.10 | -35.89 | -34.75 | -46.51 | -39.67 | 59.85 | 64.75 | -64.06 | -76.91 | 2.31 | -- | 0.237 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Nano-X Imaging Ltd | 10.13m | -57.47m | 356.25m | 164.00 | -- | 2.03 | -- | 35.17 | -0.9974 | -0.9974 | 0.1755 | 2.99 | 0.0482 | -- | 6.89 | 61,756.10 | -27.33 | -30.98 | -29.96 | -35.10 | -81.80 | -- | -567.41 | -1,527.24 | 5.09 | -- | 0.0181 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Anika Therapeutics Inc | 166.88m | -74.18m | 377.32m | 357.00 | -- | 1.80 | -- | 2.26 | -5.06 | -5.06 | 11.35 | 14.17 | 0.5642 | 1.34 | 4.73 | 467,451.00 | -25.08 | -5.41 | -27.37 | -5.87 | 62.16 | 60.70 | -44.45 | -12.60 | 3.96 | -- | 0.00 | -- | 6.67 | 9.56 | -456.34 | -- | 3.11 | -- |
| Butterfly Network Inc | 71.08m | -108.96m | 380.51m | 225.00 | -- | 1.96 | -- | 5.35 | -0.5236 | -0.5236 | 0.3407 | 0.9144 | 0.2229 | 0.6382 | 4.19 | 315,911.10 | -34.17 | -- | -39.55 | -- | 27.73 | -- | -153.29 | -- | 3.20 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| MaxCyte Inc | 45.44m | -35.43m | 431.20m | 143.00 | -- | 1.94 | -- | 9.49 | -0.3408 | -0.3408 | 0.437 | 2.11 | 0.1739 | 0.4741 | 7.46 | 317,762.90 | -13.56 | -13.18 | -14.25 | -14.33 | 88.43 | 88.79 | -77.97 | -62.96 | 13.40 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
Data as of Sep 20 2024. Currency figures normalised to Clearpoint Neuro Inc's reporting currency: US Dollar USD
19.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 1.36m | 4.96% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.27m | 4.62% |
| Taylor Frigon Capital Management LLCas of 30 Jun 2024 | 424.54k | 1.55% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 416.28k | 1.52% |
| CM Management LLCas of 30 Jun 2024 | 375.00k | 1.37% |
| Brown Advisory LLCas of 31 Mar 2024 | 333.40k | 1.22% |
| Essex Investment Management Co. LLCas of 31 Mar 2024 | 329.88k | 1.20% |
| Geode Capital Management LLCas of 30 Jun 2024 | 283.12k | 1.03% |
| Cahill Wealth Management LLCas of 31 Mar 2024 | 244.39k | 0.89% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 197.82k | 0.72% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
